Pricing Log in Create free account

Arvinas, Inc. (ARVN) vs MapLight Therapeutics, Inc. (MPLT)

Arvinas, Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. Arvinas, Inc. and MapLight Therapeutics, Inc. are of similar size ($499.6M and $490.7M). MapLight Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 57.3×. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs −348.4%). Across the 13 metrics below, Arvinas, Inc. leads on 7 and MapLight Therapeutics, Inc. on 6.

Valuation

Metric ARVN MPLT Biotechnology median
P/E 57.31 n/m 8.56
P/S 1.52 n/m 10.17
P/B 0.86 1.12 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA 4.67 n/m 0.69
EV/Sales (0.26) n/m 9.64
Earnings yield 1.74% (491.98%) (29.41%)
Free cash flow yield (43.25%) (44.82%) (23.50%)

Profitability

Metric ARVN MPLT Biotechnology median
Gross margin 97.16% — 65.16%
Operating margin (5.72%) 0.00% 0.00%
Net margin 2.94% 0.00% 0.00%
Free cash flow margin (65.93%) 0.00% 0.00%
Return on equity 1.59% (297.18%) (56.66%)
Return on assets 1.17% (124.79%) (49.22%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric ARVN MPLT Biotechnology median
Revenue growth (TTM) (15.05%) — 5.64%
EPS growth (last fiscal year) 58.84% 82.39% 30.08%
Revenue growth, 5-year CAGR 58.93% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ARVN MPLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.91 16.52 4.72
Net debt to EBITDA 5.62 1.79 0.96

Dividend

Metric ARVN MPLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ARVN MPLT Biotechnology median
Market cap 499.55m 490.73m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack